Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness.

Arthur MageauJulia F SimardElisabet SvenungssonElizabeth V Arkema

Published in: Lupus (2024)

Anti-SARS-CoV2 vaccination coverage was similar between SLE patients and the general population in Sweden. Even though the incidence of post-vaccination COVID-19 hospitalization was very low, vaccine effectiveness was diminished in SLE patients compared to the general population and lowest in those treated with immunosuppressants.

Keyphrases

sars cov
end stage renal disease
systemic lupus erythematosus
newly diagnosed
ejection fraction
chronic kidney disease
systematic review
peritoneal dialysis
disease activity
prognostic factors
risk factors
rheumatoid arthritis
patient reported outcomes
health insurance